Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
The M-type K+ current [IK(M)] activates in response to membrane depolarization and regulates neuronal excitability. Mutations in two subunits (KCNQ2 and KCNQ3; Kv7.2 and Kv7.3) that underlie the M-channel cause the human seizure disorder benign familial neonatal convulsions (BFNC), presumably by reducing IK(M) function. In mice, the Szt1 mutation, which deletes the genomic DNA encoding the KCNQ2 C terminus and all of CHRNA4 (nicotinic acetylcholine receptor alpha4 subunit) and ARFGAP-1 (GTPase-activating protein that inactivates ADP-ribosylation factor 1), reduces seizure threshold, and alters M-channel pharmacosensitivity. Genomic deletions affecting the C terminus of KCNQ2 have been identified in human families with BFNC, and truncation of the C terminus prevents proper KCNQ2/KCNQ3 channel assembly in Xenopus oocytes. We showed previously that Szt1 mice have a reduced baseline seizure threshold and altered sensitivity to drugs that act at the M-channel. Specifically, the proconvulsant M-channel blocker linopirdine and anticonvulsant enhancer retigabine display increased and decreased potency, respectively, in Szt1 mice. To investigate the effects of the Szt1 mutation on IK(M) function explicitly, perforated-patch electrophysiology was performed in CA1 pyramidal neurons of the hippocampus in brain slices prepared from C57BL/6J-Szt1/+ and control C57BL/6J+/+ mice. Our results show that Szt1 reduces both IK(M) amplitude and current density, inhibits spike frequency adaptation, and alters many aspects of M-channel pharmacology. This is the first evidence that a naturally occurring Kcnq2 mutation diminishes the amplitude and function of the native neuronal IK(M), resulting in significantly increased neuronal excitability. Finally, the changes in single-cell biophysical properties likely underlie the altered seizure threshold and pharmacosensitivity reported previously in Szt1 mice.
Aiken,
Reduction of spike frequency adaptation and blockade of M-current in rat CA1 pyramidal neurones by linopirdine (DuP 996), a neurotransmitter release enhancer.
1995, Pubmed
Aiken,
Reduction of spike frequency adaptation and blockade of M-current in rat CA1 pyramidal neurones by linopirdine (DuP 996), a neurotransmitter release enhancer.
1995,
Pubmed Barton,
The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs.
2004,
Pubmed Bertrand,
How mutations in the nAChRs can cause ADNFLE epilepsy.
2002,
Pubmed
,
Xenbase Biervert,
A potassium channel mutation in neonatal human epilepsy.
1998,
Pubmed
,
Xenbase Brown,
Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone.
1980,
Pubmed Castaldo,
Benign familial neonatal convulsions caused by altered gating of KCNQ2/KCNQ3 potassium channels.
2002,
Pubmed
,
Xenbase Constanti,
M-Currents in voltage-clamped mammalian sympathetic neurones.
1981,
Pubmed Devaux,
KCNQ2 is a nodal K+ channel.
2004,
Pubmed Dost,
The anticonvulsant retigabine potently suppresses epileptiform discharges in the low Ca ++ and low Mg++ model in the hippocampal slice preparation.
2000,
Pubmed Flagmeyer,
General pharmacology of the putative cognition enhancer linopirdine.
1995,
Pubmed Goh,
Pharmacological and physiological properties of the after-hyperpolarization current of bullfrog ganglion neurones.
1987,
Pubmed Hadley,
Differential tetraethylammonium sensitivity of KCNQ1-4 potassium channels.
2000,
Pubmed Hirose,
A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy.
1999,
Pubmed Li,
Single-channel analysis of KCNQ K+ channels reveals the mechanism of augmentation by a cysteine-modifying reagent.
2004,
Pubmed Marrion,
Control of M-current.
1997,
Pubmed McColl,
Electroencephalographic characterisation of pentylenetetrazole-induced seizures in mice lacking the alpha 4 subunit of the neuronal nicotinic receptor.
2003,
Pubmed Otto,
Mice carrying the szt1 mutation exhibit increased seizure susceptibility and altered sensitivity to compounds acting at the m-channel.
2004,
Pubmed Otto,
Effects of the anticonvulsant retigabine on cultured cortical neurons: changes in electroresponsive properties and synaptic transmission.
2002,
Pubmed Passmore,
KCNQ/M currents in sensory neurons: significance for pain therapy.
2003,
Pubmed Pereira,
Complete loss of the cytoplasmic carboxyl terminus of the KCNQ2 potassium channel: a novel mutation in a large Czech pedigree with benign neonatal convulsions or other epileptic phenotypes.
2004,
Pubmed Peretz,
Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties.
2005,
Pubmed Peters,
Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior.
2005,
Pubmed
,
Xenbase Romero,
Newly developed blockers of the M-current do not reduce spike frequency adaptation in cultured mouse sympathetic neurons.
2004,
Pubmed Ross,
Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse.
2000,
Pubmed Rostock,
D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures.
1996,
Pubmed Scheffer,
The genetics of human epilepsy.
2003,
Pubmed Schroeder,
Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy.
1998,
Pubmed
,
Xenbase Schwake,
A carboxy-terminal domain determines the subunit specificity of KCNQ K+ channel assembly.
2003,
Pubmed
,
Xenbase Selyanko,
Properties of single M-type KCNQ2/KCNQ3 potassium channels expressed in mammalian cells.
2001,
Pubmed Shah,
Molecular correlates of the M-current in cultured rat hippocampal neurons.
2002,
Pubmed Singh,
A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns.
1998,
Pubmed Steinlein,
Genetic mechanisms that underlie epilepsy.
2004,
Pubmed Steinlein,
A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy.
1995,
Pubmed Watanabe,
Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability.
2000,
Pubmed Wong,
Proconvulsant-induced seizures in alpha(4) nicotinic acetylcholine receptor subunit knockout mice.
2002,
Pubmed Yang,
Spontaneous deletion of epilepsy gene orthologs in a mutant mouse with a low electroconvulsive threshold.
2003,
Pubmed Yue,
KCNQ/M channels control spike afterdepolarization and burst generation in hippocampal neurons.
2004,
Pubmed
